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Editorial
Who benefits from global certification of polio eradication?
Only two decades ago, 500 to 1000 children were
developing polio every day in India1. The unfortunate
victims were predominantly  infants and children in
families with low income, little or no education and
poor understanding and access to prophylactic
immunization programmes. A friend described them
as the most innocent of innocent individuals, who
became disabled due to the sins of omission and of
commission of the government health system. These
un-numbered un-named infants, who would have been
paralysed but for the eradication efforts, are the real
beneficiaries of this huge project thrust upon or taken
on willy-nilly by the system.
We owe much to the leadership of the World
Health Organisation (WHO) for having spearheaded
this enormous global effort. It was made possible by
the visionary initiative of the Rotary International and
the co-operation of the United Nations International
Children’s Emergency Fund and the US Centres for
Disease Control and Prevention. Some US $ 3 billion
dollars have already been spent globally by these
international agencies in partnership; developing
countries together would have spent perhaps an equal
amount; and volunteers have absorbed the huge cost
of their time and resources. The US $ 3 billion dollars
came from the richest of the rich in the world, and
we salute them for their generosity. Their money is
well spent, for the benefit of the poorest of the poor,
bringing equity in benefit to all children of the world,
a game in which all sides win. In India the
govenrments and staff at central, state and
panchayati levels as well as the Indian Academy of
Pediatrics, other health professional organizations,
medical practitioners from public and private sectors
and literally millions of Rotary and other volunteers
have worked hard over the last nearly one decade to
bring down the incidence of polio to near zero level.
Now we wait for finishing the remaining task in India
so that the South East Asian Region could be certified
free of wild poliovirus transmission three years later.
The WHO Region of the Americas, Western
Pacific Region and European Region have already
been certified free of indigenous wild poliovirus.
Hopefully the remaining polio-endemic Regions also
- African and Eastern Mediterranean - will be so
certified in the near future, perhaps by 2008.  Each
Region has its own ‘Regional Certification
Commission (RCC)’ that will certify the absence of
indigenous wild poliovirus. The importation of wild
virus from another yet uncertified region does not
jeopardize the certified status, if its transmission is
contained soon. In the past, the RCCs had not taken
the laboratory containment of wild poliovirus into
account for certification, but it is not clear if the ground
rule will be altered for the remaining Regions2.
The ‘Global Commission for the Certification of
the Eradication of Poliomyelitis (GCC)’ will oversee
polio eradiation certification activities at the global
level2. According to the GCC, global eradication is
defined as “the eradication of all  wild polioviruses;
the occurrence of poliomyelitis caused by vaccine
viruses will not invalidate certification2”. Therefore
what the GCC intends to certify is the eradication of
only wild viruses2. The GCC has requested the WHO
to develop a separate process to verify the absence
of circulating vaccine-derived polioviruses in the post-
certification era2. This state of affairs leaves much
to be desired.
The world has only one precedent to go by, namely
the certification of smallpox eradication. The message
to the world was that vaccination was no longer
necessary once eradication was certified, for there
was no more fear of natural smallpox virus
transmission. Countries were left to their own timing
to stop vaccination. Based on this experience and
relevant scientific theories, the authoritative definition
of eradication of any infectious disease is the
“permanent reduction to zero of the worldwide
incidence of infection caused by a specific agent as
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a result of deliberate efforts; intervention measures
are no longer needed3”. Thus, the message from the
certification of the global eradication of poliomyelitis
by the GCC ought to be that further intervention, polio
immunization in other words, will no longer be
necessary. Anything short of this endpoint for global
certification by the GCC will not be helpful for
developing countries like India to decide on
discontinuing immunization.
When the sixth and last of the WHO Regions will
be certified that indigenous wild poliovirus infection
has been eliminated, there will be no country from
where it could be imported to any other virus-free
country. In other words, the last Regional certification
heralds the global absence of wild virus transmission.
A separate process of re-certifying all Regions will
not only be unnecessary but also liable for
misinterpretation. The meaningful global certification
should be the clear signal that polio immunization may
be discontinued without risk not only for countries
that stop immunization but also for the those  that
may wish to continue immunization. Moreover, the
rich paid for polio eradication partly on the promise
of perpetual profit from discontinuing polio
immunization and the world owes them that much in
gratitude. Any country that decides to discontinue
polio immunization will share in this economic saving,
for win-win equity among the poor and the rich. What
are the pre-reaquisities for such certification?
Vaccinia virus is a heterologous species from
smallpox virus, and neither did it cause smallpox nor
did it spread (for all practical purposes) from person
to person. Oral poliovirus vaccine, on the contrary, is
not completely avirulent, but causes vaccine-
associated paralytic polio (VAPP) that is
indistinguishable from wild-virus polio in its incubation
period, severiity, clinical manifestations, pathology and
case fatality. The viruses are also transmissible
person-to-person. Such transmission results in
nucleotide substitutions tending to take the progeny
towards the wild phenotype in neurovirulence and
transmissibility. In Egypt, such a vaccine-derived
virus regained all characteristics of the wild virus,
including efficient growth at high temperature, after
uninterrupted circulation for about 10 yr4. Anticipating
such problems it has been proposed that true
eradication of polioviruses should be defined as zero
incidence of infection with wild and vaccine viruses5.
In short, what the world needs from the GCC is
certification after all risks from wild and vaccine virus
infection are removed. If GCC will not do this, then
who else should certify eradication to usher in an era
when polio vaccination can be safely stopped?
The pre-requisities for such meaningful global
certification of the eradication of infectious
polioviruses include: (i) the last Region certified free
of wild virus; (ii) early discontinuation of oral polio
vaccination in every country; (iii) continued
surveillance for a sufficient length of period for any
surviving chain of transmission of vaccine-derived
virus; (iv) interruption of such chains if detected; and
(v) the thoughtful decisions of the GCC to ensure
laboratory containment in all Regions.
If wild viruses could be eradicated, certainly it
should be easier to eradicate vaccine viruses that are
less efficient in transmission and continued circulation.
USA and Canada in North America and France and
Germany in Europe have already shown the world
the proof of principle of the elimination of vaccine-
virus infection. My intention here is not to prescribe
how to achieve the true global eradication, but rather
to point out the urgency to do it. If it cannot be
achieved without introducing inactivated poliovirus
vaccine, so be it. The WHO and all partners, global,
regional and national, must lose no time to re-think
the ground rules and tactics for achieving and
certifying the zero incidence of poliovirus infection
everywhere. That will be a monumental global public
health achievement and could well be the most
prominent feather in WHO’s cap.
T. Jacob John
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